Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ALIVE Israel HealthTech Fund, based in Savyon, Israel, specializes in mid-to-late stage investments in HealthTech. The fund supports companies through the entire investment journey, from clinical trials to market adoption. ALIVE manages a portfolio of 11 companies and collaborates with leading hospital chains, HMOs, and financial institutions.
ALIVE invests in mid-to-late stage companies developing platform technologies in healthcare, digital health, biotech, and AI. The fund targets investments in medical devices, diagnostics, healthcare IT, and artificial intelligence, seeking firms with strong management and a solid execution track record.
Notable portfolio companies include Medisafe, a digital therapeutics firm; Innovalve, which develops an artificial mitral valve; Cynerio, offering a Healthcare IoT Platform; and Beyeonics Vision, focused on AR solutions for ophthalmic surgeries. Other companies in their portfolio include Nevia Bio, OncoHost, Navina, Wisdo, Append Medical, and Vessi Medical.
Email your pitch deck to shir@alivevc.com for consideration.
Yes, ALIVE typically leads investment rounds in the companies they back, particularly in mid-to-late stage funding.
ALIVE is open to follow-on investments, especially for companies that demonstrate strong growth and potential for further development.
The specific size of ALIVE's current fund is not publicly disclosed, but it focuses on mid-to-late stage investments across various HealthTech sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.